68084-556 : Tolazamide 250 mg Oral Tablet


NDC: 68084-556
Labeler: American Health Packaging
Product Type: Human Prescription Drug
Drug Name:  Tolazamide
Dosage Form: Oral Tablet
Application #: ANDA070259
Rev. Date: 


Appearance:


Markings: MYLAN;217;250
Shapes:  Round
Colors:  White
Size (mm): 10
Segments: * 2

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces.

MYLAN 217 250: (0378-0217) Tolazamide 250 mg Oral Tablet by American Health Packaging
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 68084-556-21: 3 BLISTER PACK IN 1 CARTON (68084‑556‑21) > 10 TABLET IN 1 BLISTER PACK (68084‑556‑11)

Active Ingredients:

  • Tolazamide

Dosage Strength:

  • 250 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Croscarmellose Sodium
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Sodium Lauryl Sulfate

Pharmaceutical Classes:

  • Sulfonylurea [EPC]
  • Sulfonylurea Compounds [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 0378-0217 Tolazamide 250 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-0551 Tolazamide 500 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 53489-151 Tolazamide 100 mg Oral Tablet by Mutual Pharmaceutical Company, Inc
  • 53489-152 Tolazamide 250 mg Oral Tablet by Mutual Pharmaceutical Company, Inc
  • 53489-153 Tolazamide 500 mg Oral Tablet by Mutual Pharmaceutical Company, Inc
  • 55289-265 Tolazamide 250 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68084-556 QR Code

< Prev: 68084-555Next: 68084-558 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.